论文部分内容阅读
目的:探讨分析综合介入治疗原发性肝癌的临床效果。方法:选取2014年8月~2015年8月期间在我院收治的46例原发性肝癌患者,将其随机分为观察组和对照组,每组各23例,对照组采用TACE进行治疗,观察组给予TACE联合其他治疗的综合介入治疗,比较两组患者的肿瘤缩小率、临床疗效及1年生存率。结果:观察组患者肿瘤缩小率为91.3%,有效率为82.6%,1年生存率为78.3%,均明显高于对照组,P<0.05,差异具有统计学意义。结论:采用TACE+PEI、TACE+RFA等综合介入治疗方法治疗原发性肝癌具有较好的疗效,可提高患者生存率,值得推广应用。
Objective: To investigate the clinical effect of comprehensive interventional treatment of primary liver cancer. Methods: Forty-six patients with primary liver cancer admitted to our hospital from August 2014 to August 2015 were randomly divided into observation group and control group, with 23 cases in each group. The control group was treated with TACE, The observation group was given comprehensive interventional therapy of TACE combined with other treatments. The tumor shrinkage rate, clinical efficacy and 1-year survival rate were compared between the two groups. Results: The reduction rate of tumor in observation group was 91.3%, the effective rate was 82.6% and the 1-year survival rate was 78.3%, which were significantly higher than that of control group (P <0.05). The difference was statistically significant. Conclusion: TACE + PEI, TACE + RFA and other comprehensive interventional treatment of primary liver cancer has a good effect, can improve the survival rate of patients, it is worth promoting the application.